ID   NSHDMUi001-A
AC   CVCL_D0K9
SY   20201217LJJ
DR   BioSamples; SAMEA112650128
DR   hPSCreg; NSHDMUi001-A
DR   Wikidata; Q123033198
RX   PubMed=37028179;
CC   From: Department of Neurology, Second Hospital of Dalian Medical University; Dalian; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37028179
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 8,9
ST   D18S51: 13,15
ST   D19S433: 15.2,16.2
ST   D21S11: 31
ST   D2S1338: 21,24
ST   D2S441: 10,12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 23,27
ST   Penta D: 8,9
ST   Penta E: 5,14
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,19
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=37028179; DOI=10.1016/j.scr.2023.103087;
RA   Li P.-X., Wang C., Wang J.-T., Tan J., Liu Y.-Z., Lin Y.-Z.;
RT   "Generation of an induced pluripotent stem cell lines NSHDMUi001-A
RT   from patients with type 2 diabetes.";
RL   Stem Cell Res. 69:103087-103087(2023).
//